Author:
Obara Seiji,Yamamoto Kazumi,Hosogai Nao,Yoshimura Yasuro
Subject
Cancer Research,Oncology,Oral Surgery
Reference21 articles.
1. Antitumor activity of 1M tegafur-0.4M 5-chloro-2,4-dihydroxypyrimidine-1M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats;Shirasaka;Cancer Res,1996
2. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators;Shirasaka;Anticancer Drugs,1995
3. Clinical implication of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1);Miyamoto;Int J Oncol,2000
4. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity;Etienne;J Clin Oncol,1995
5. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis;Inokuchi;Cancer Chemother Phrmacol,2004
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献